Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Oncology (25)
- Radiology (11)
- Medical Sciences (10)
- Life Sciences (8)
- Bioinformatics (7)
-
- Biomedical Informatics (7)
- Diseases (5)
- Physical Sciences and Mathematics (3)
- Anatomy (2)
- Neoplasms (2)
- Pediatrics (2)
- Public Health (2)
- Amino Acids, Peptides, and Proteins (1)
- Artificial Intelligence and Robotics (1)
- Biomedical (1)
- Cancer Biology (1)
- Cell and Developmental Biology (1)
- Chemicals and Drugs (1)
- Chemistry (1)
- Computer Sciences (1)
- Critical Care (1)
- Data Science (1)
- Digestive System (1)
- Digestive System Diseases (1)
- Electrical and Computer Engineering (1)
- Engineering (1)
- Environmental Public Health (1)
- Institution
- Publication
-
- Faculty, Staff and Student Publications (7)
- Department of Radiation Oncology Faculty Papers (6)
- Dissertations and Theses (Open Access) (5)
- Department of Radiation Oncology (3)
- Masters Projects (3)
-
- Chemistry & Biochemistry Faculty Publications (1)
- Faculty, Staff and Students Publications (1)
- Health Physics and Diagnostic Sciences Faculty Research (1)
- Honors Projects (1)
- LSU Master's Theses (1)
- Posters (1)
- Radiation Medicine Faculty Publications (1)
- Radiologic Sciences (1)
- Student Research Poster Presentations 2021 (1)
- Publication Type
Articles 31 - 33 of 33
Full-Text Articles in Radiation Medicine
Solitary Brain Metastasis: A Rare Initial Presentation Of Prostate Carcinoma, Asim Hafiz, Muneeb Uddin Karim, Bilal Mazhar Qureshi, Adnan Jabbar, Zubair Ahmad
Solitary Brain Metastasis: A Rare Initial Presentation Of Prostate Carcinoma, Asim Hafiz, Muneeb Uddin Karim, Bilal Mazhar Qureshi, Adnan Jabbar, Zubair Ahmad
Department of Radiation Oncology
Cerebral metastasis as an initial clinical presentation of prostate carcinoma is extremely rare. Usually, patients have widespread metastasis in the body before presenting with brain metastasis. In the absence of extensive metastasis, especially without bony metastasis, only brain metastasis is an unusual presentation of the disease. We report a case of a 59-years-old patient who presented with a lack of concentration and decreased vision. Magnetic resonance imaging (MRI) of the brain revealed a large right parietal-occipital space-occupying lesion. He underwent surgery and the pathological diagnosis of the tumor turned out to be metastatic prostate carcinoma. Further evaluation by a whole-body …
Sub-Region Based Radiomics Analysis For Survival Prediction In Oesophageal Tumours Treated By Definitive Concurrent Chemoradiotherapy, Congying Xie, Pengfei Yang, Xuebang Zhang, Lei Xu, Xiaoju Wang, Xiadong Li, Luhan Zhang, Ruifei Xie, Ling Yang, Zhao Jing, Hongfang Zhang, Lingyu Ding, Yu Kuang, Tianye Niu, Shixiu Wu
Sub-Region Based Radiomics Analysis For Survival Prediction In Oesophageal Tumours Treated By Definitive Concurrent Chemoradiotherapy, Congying Xie, Pengfei Yang, Xuebang Zhang, Lei Xu, Xiaoju Wang, Xiadong Li, Luhan Zhang, Ruifei Xie, Ling Yang, Zhao Jing, Hongfang Zhang, Lingyu Ding, Yu Kuang, Tianye Niu, Shixiu Wu
Health Physics and Diagnostic Sciences Faculty Research
Background: Evaluating clinical outcome prior to concurrent chemoradiotherapy remains challenging for oesophageal squamous cell carcinoma (OSCC) as traditional prognostic markers are assessed at the completion of treatment. Herein, we investigated the potential of using sub-region radiomics as a novel tumour biomarker in predicting overall survival of OSCC patients treated by concurrent chemoradiotherapy. Methods: Independent patient cohorts from two hospitals were included for training (n = 87) and validation (n = 46). Radiomics features were extracted from sub-regions clustered from patients' tumour regions using K-means method. The LASSO regression for ‘Cox’ method was used for feature selection. The survival prediction model …
Combining Radiation And Immune Checkpoint Blockade In The Treatment Of Head And Neck Squamous Cell Carcinoma., Gregor Manukian, Voichita Bar-Ad, Bo Lu, Athanassios Argiris, Jennifer M. Johnson
Combining Radiation And Immune Checkpoint Blockade In The Treatment Of Head And Neck Squamous Cell Carcinoma., Gregor Manukian, Voichita Bar-Ad, Bo Lu, Athanassios Argiris, Jennifer M. Johnson
Department of Radiation Oncology Faculty Papers
Head and neck squamous cell carcinoma (HNSCC) is a significant cause of morbidity and mortality worldwide. Current treatment options, even though potentially curative, have many limitations including a high rate of complications. Over the past few years immune checkpoint inhibitors (ICI) targeting cytotoxic lymphocyte antigen-4 (CTLA-4), programmed cell death protein 1 (PD-1), and programmed cell death ligand 1 (PD-L1) have changed treatment paradigms in many malignancies and are currently under investigation in HNSCC as well. Despite improvements in treatment outcomes and the implementation of combined modality approaches long-term survival rates in patients with locally advanced HNSCC remain suboptimal. Accumulating evidence …